A multinational consortium including Korean conglomerate GS Group has become the largest shareholder of major medical aesthetics firm Hugel Pharma Co, Ltd, marking the biggest ever biopharma acquisition in South Korea.
Through the deal, worth KRW1.7tn ($1.46bn), Hugel’s largest shareholder Leguh Issuer Designated Activity Company (LIDAC), part of Bain Capital, has...







